comparemela.com

Latest Breaking News On - Phd md anderson cancer center - Page 1 : comparemela.com

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force | Breast Cancer | JAMA

This modeling study uses Cancer Intervention and Surveillance Modeling Network models and national data on breast cancer incidence, mammography

United statesUniversity of texasSarahm temkinGil quessepVan ravesteynYa chen tina shihJulie mcgregorYing luMunoz medinaLinn abrahamHannah johnsonAdela biosciencesYifan luAmy trentham dietzElizabeth webberDoug owens

Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024

COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC)

Dana farber cancer instituteUnited statesDsenthil damodaranSimon jenkinsPaul plourdeElizabeth attiasDavid portmanBarry kommMiriam portmanHarvard medical schoolParke davis pharmaceuticalsUniversity of miamiSermonix pharmaceuticals incPhd md anderson cancer centerHospital cancer centerPhd harvard medical school

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the developm.

San diegoUnited statesRichard waldronMecbotamab vedotinBruce mackleLung cancer research foundationAndrew sabin foundationLungevity foundationJohns hopkins universityCancer research prevention institute of texasExchange commissionAmerican society of clinical oncologyOffice of orphan drug productsYork university school of medicineDepartment of thoracic head neck medical oncologyMd anderson cancer center

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation.

United statesJohn mullalyJamesp allisonMichaela curranJacques bouchyPatricia lorussoDo yale school of medicine cancer centerKineta incPhasei clinical trials programAmerican cancer society levy fellowshipMemorial sloan kettering cancer centerEisenberg centerLifesci advisorsCancer centerYale cancer centerInvestor relations business development

Ryvu Therapeutics & Collaborators to Present Clinical and Translational Data from RVU120 and SEL24/MEN1703 at the 63rd ASH Annual Meeting & Exposition and the 44th Annual SABCS

/PRNewswire/ Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address.

United statesSan antonioTomasz rzymskiPawel przewiezlikowskiSujan piyaMd washington universityMd anderson cancer centerWarsaw stock exchangeSaint louis washington university school of medicinePhd md anderson cancer centerHenryb gonzalez convention centreMenarini groupAlessandro paoli menarini groupAmerican society of hematology annual meeting expositionProgram numberAmerican society

vimarsana © 2020. All Rights Reserved.